한국형 범불안장애 약물치료 알고리듬 2009 ( I ) : 초기 치료 전략
Korean Medication Algorithm Project for Generalized Anxiety Disorder 2009 (I) : Initial Treatment Strategy
1
조회
0
다운로드
2
인용
0
참고문헌
초록
ObjectivesZZThis study investigated the consensus about treatment strategies for the initial treatment of generalized anxiety disorder (GAD). This issue represents one of the subjects addressed by the Korean Medication Algorithm Project for GAD in Korea. MethodsZZThe executive committee of the Korean Medication Algorithm Project for GAD, support-ed by The Korean Association of Anxiety Disorders, developed questionnaires about treatment st-rategies for patients with GAD, based on guidelines or algorithms and clinical trial studies previously published in foreign countries, especially by the International Psychopharmacology Algori-thm Project, the National Institute for Clinical Excellence, and the Canadian Psychiatric Associat-ion. Fifty-five (64%) of 86 experts on a committee reviewing GAD in Korea responded to the quest-ionnaires. We classified the consensus of expert opinions into three categories (first-line, second-line, and third-line treatment strategies) and identified the treatment of choice according using a Chi-square test and a 95% confidence interval. ResultsZZFor the initial treatment of GAD, antidepressant monotherapy and the combination of antidepressants and benzodiazepines as anxiolytics were recommended as the first line strategies. Escitalopram, paroxetine CR and venlafaxine XR were selected as first-line antidepressant tr-eatments, and alprazolam, clonazepam and lorazepam were the preferred benzodiazepines. The mean starting doses and mean maximum doses of the drugs were 7.55±3.09 mg and 24.91±8.14 mg for escitalopram, 12.57±2.83 mg and 44.76±15.00 mg for paroxetine CR, and 46.81±16.74 mg and 223.32±60.64 mg for venlafaxine XR. ConclusionZZThese results, which reflect recent studies and clinical experiences, may provide guidelines for the initial.
Abstract
ObjectivesZZThis study investigated the consensus about treatment strategies for the initial treatment of generalized anxiety disorder (GAD). This issue represents one of the subjects addressed by the Korean Medication Algorithm Project for GAD in Korea. MethodsZZThe executive committee of the Korean Medication Algorithm Project for GAD, support-ed by The Korean Association of Anxiety Disorders, developed questionnaires about treatment st-rategies for patients with GAD, based on guidelines or algorithms and clinical trial studies previously published in foreign countries, especially by the International Psychopharmacology Algori-thm Project, the National Institute for Clinical Excellence, and the Canadian Psychiatric Associat-ion. Fifty-five (64%) of 86 experts on a committee reviewing GAD in Korea responded to the quest-ionnaires. We classified the consensus of expert opinions into three categories (first-line, second-line, and third-line treatment strategies) and identified the treatment of choice according using a Chi-square test and a 95% confidence interval. ResultsZZFor the initial treatment of GAD, antidepressant monotherapy and the combination of antidepressants and benzodiazepines as anxiolytics were recommended as the first line strategies. Escitalopram, paroxetine CR and venlafaxine XR were selected as first-line antidepressant tr-eatments, and alprazolam, clonazepam and lorazepam were the preferred benzodiazepines. The mean starting doses and mean maximum doses of the drugs were 7.55±3.09 mg and 24.91±8.14 mg for escitalopram, 12.57±2.83 mg and 44.76±15.00 mg for paroxetine CR, and 46.81±16.74 mg and 223.32±60.64 mg for venlafaxine XR. ConclusionZZThese results, which reflect recent studies and clinical experiences, may provide guidelines for the initial.
참고문헌 (16)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2000), American Psychiatry Association
- Ballenger JC, "Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety", J Clin Psychiatry, 62(Suppl 11), pp.53~58 (2001)
- Sadock BJ, "Kaplan and Sadock’s Synopsis of psychiatry" (2007), Lippincott Williams & Wilkins
- "Clinical guideline 22, Management of anxiety (panic disorder, with or without agoraphobia, and GAD) in adults in primary, secondary and community care"[URL]
- Swinson RP, "Clinical practice guidelines. Management of anxiety disorders", Can J Psychiatry, 51, pp.51S~55S (2006)
- Jonathan RT, "Pharmacotherapy of generalized anxiety disorder", J Clin Psychiatry, 62(suppl 11), pp.46~50 (2001)
- Mitte K, "A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder", J Clin Psychopharmacol, 25, pp.141~150 (2005)
- 김찬형, "범불안장애 약물치료의 최신 경향", 대한정신약물학회지, 15(1), pp.9~13 (2004), 대한정신약물학회
- 박주언, "범불안장애에서 서방형 Venlafaxine의 6개월간 치료 효과: 전향적, 다기관, 개방 연구", 대한정신약물학회지, 17(1), pp.50~59 (2006), 대한정신약물학회
- "Antidepressant for generalized anxiety disorder(review)"[URL]
- Bandelow B, "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders", World J Biol Psychiatry, 3, pp.171~199 (2002)
- Bandelow B, "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-first revision", World J Biol Psychiatry, 9, pp.248~312 (2008)
- Baldwin DS, "Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology", J Psychopharmacol, 19, pp.567~596 (2005)
- "General Anxiety Disorder (GAD) Algorithm: Online Flowchart"[URL]
- Davidson JR, "A psychopharmacological treatment algorithm for generalized anxiety disorder (GAD)", J Psychopharmacol, 24, pp.3~26 (2010)
- Schweizer E, "Strategies for treatment of generalized anxiety in the primary care setting", J Clin Psychiatry, 58(Suppl 3), pp.27~31 (1997)